ArticleAdvanced therapeutics2022

Efficacy and Safety of Inosine Pranobex in COVID-19 Patients: A Multicenter Phase 3 Randomized Double-Blind, Placebo-Controlled Trial.

Jayanthi C R et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.